Royalty Pharma plc Profile Avatar - Palmy Investing

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]
Strategy & Leadership

Executives & BofD Beta

Total Compensation ($)

Scope

Executives

Yet No Data For Executives

Directors

Yet No Data For Directors

C-Suite and VPs/SVPs

Yet No Data For Executives

Board of Directors (BofD)

Yet No Data For Directors

End of RPRX's Analysis
CIK: 1802768 CUSIP: G7709Q104 ISIN: GB00BMVP7Y09 LEI: - UEI: -
Secondary Listings
RPRX has no secondary listings inside our databases.